GC Cell (XKRX:144510) ROCE % : -6.30% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is GC Cell ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. GC Cell's annualized ROCE % for the quarter that ended in Mar. 2024 was -6.30%.

GC Cell ROCE % Historical Data

The historical data trend for GC Cell's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GC Cell ROCE % Chart

GC Cell Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-5.95

9.84

12.92

6.78

-0.69

GC Cell Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															-0.85	-0.89	-1.85	0.81	-6.30

GC Cell ROCE % Calculation

GC Cell's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-4055.013	/	( ( (676530.629 - 88115.471)	+	(665173.377 - 76816.032) )	/ 2 )
	=	-4055.013	/	( (588415.158	+	588357.345)	/ 2 )
	=	-4055.013	/	588386.2515
	=	-0.69 %

GC Cell's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-36696.996	/	( ( (665173.377 - 76816.032)	+	(661905.75 - 84843.241) )	/ 2 )
	=	-36696.996	/	( ( 588357.345	+	577062.509 )	/ 2 )
	=	-36696.996	/	582709.927
	=	-6.30 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

GC Cell (XKRX:144510) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

GC Cell ROCE % Related Terms

Thank you for viewing the detailed overview of GC Cell's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

GC Cell (XKRX:144510) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GC Cell Corp (XKRX:144510) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

30 beongil to giheung-gu, Gyeonggi, 107 Lee Hyun, Yongin, KOR, 16 924

Website

https://www.gccell.com

GC Cell Corp engages in the provision of anti-cancer immunotherapy. The company is developing an anticancer drug, which is in Phase II clinical trials; and stem cell treatment drugs. It also provides cell banking, sample inspection, clinical trial, and bio logistics services.

GC Cell (XKRX:144510) Headlines

No Headlines